[Federal Register Volume 62, Number 73 (Wednesday, April 16, 1997)]
[Notices]
[Page 18632]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-9902]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Vaccine Advisory Committee (NVAC), Subcommittee on 
Vaccine Safety, Subcommittee on Immunization Coverage, Subcommittee on 
Future Vaccines, and the Advisory Commission on Childhood Vaccines 
(ACCV) Subcommittee on Vaccine Safety: Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and dates: 8:45 a.m.-12:15 p.m., May 1, 1997. 8:30 a.m.-
1:15 p.m., May 2, 1997.
    Place: Hubert H. Humphrey Building, Room 703A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Notice: In the interest of security, the Department has 
instituted stringent procedures for entrance to the Hubert H. 
Humphrey Building by non-government employees. Thus, persons without 
a government identification card should plan to arrive at the 
building each day either between 8 and 8:30 a.m. or 12:30 and 1 p.m. 
so they can be escorted to the meeting. Entrance to the meeting at 
other times during the day cannot be assured.
    Purpose: This committee advises and makes recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program responsibilities.
    Matters to be discussed: Agenda items will include a National 
Vaccine Program Office (NVPO) update; a discussion on review of the 
Department of Health and Human Services' Adult Immunization Plan; a 
discussion on the survey on practices of non-traditional providers; 
a report of meeting on simian-virus-40--next steps; AIDS vaccine, 
the progress in vaccine development and organizational approach; the 
national vaccine plan focusing on priorities; tuberculosis vaccines, 
barriers and opportunites; the National Institutes of Health (NIH) 
will discuss their program on tuberculosis and vaccine options; 
discussion from the Advisory Council on the Elimination of 
Tuberculosis; improving immunization coverage report from the Sabin 
Foundation; report from the Subcommittee on Immunization Coverage; 
report from the Subcommittee on Future Vaccines; report from the 
Subcommittee on Vaccine Safety; and status of the Work Group on 
philosophical exemptions.
    Agenda items are subject to change as priorities dictate.

    Name: Subcommittee on Vaccine Safety and the Advisory Commission 
on Childhood Vaccines, Subcommittee on Vaccine Safety.
    Time and date: 1:15 p.m.-5 p.m., May 1, 1997.
    Place: Hubert H. Humphrey Building, Room 425A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This joint NVAC/ACCV subcommittee will review issues 
relevant to vaccine safety and adverse reactions to vaccines.
    Matters to be discussed: This subcommittee will discuss the 
update on the Public Health Service vaccine safety activities; 
vaccine safety surveillance overview; vaccine safety funding; and 
agenda items for next meeting.

    Name: Subcommittee on Immunization Coverage.
    Time and date: 1:15 p.m.-5 p.m., May 1, 1997.
    Place: Hubert H. Humphrey Building, Room 423A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee will identify and propose solutions 
that provide a multifaceted and holistic approach to reducing 
barriers that result in low immunization coverage for children.
    Matters to be discussed: This subcommittee will discuss the 
review of recommendations from the document ``Strategies to Sustain 
Immunization Coverage'; and a discussion and finalization of the 
recommendations.

    Name: Subcommittee on Future Vaccines.
    Time and date: 1:15 p.m.-5 p.m., May 1, 1997.
    Place: Hubert H. Humphrey Building, Room 405A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: The Subcommittee on Future Vaccines will develop policy 
options and guide national activities which will lead to accelerated 
development, licensure, and best use of new vaccines in the simplest 
possible immunization schedules.
    Matters to be discussed: This subcommittee will discuss an 
update on vaccine procurement strategies and case studies in vaccine 
development.

    Contact person for more information: Felecia D. Pearson, 
Committee Management Specialist, NVPO, CDC, 1600 Clifton Road, NE, 
M/S D50, Atlanta, Georgia 30333, telephone 404/639-7250.

    Dated: April 11, 1997.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 97-9902 Filed 4-15-97; 8:45 am]
BILLING CODE 4163-18-P